BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pro-Pharmaceuticals, Inc. 

189 Wells Avenue
Suite 200
Newton  Massachusetts  02459  U.S.A.
Phone: 617-559-0033 Fax: 617-928-3450


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Pro-Pharmaceuticals, Inc. (PRW) to Hold Conference Call to Provide Update Following Company’s Annual Meeting of Stockholders 5/26/2011 11:35:49 AM
Pro-Pharmaceuticals, Inc. (PRW) Changes Company Name to Galectin Therapeutics 5/26/2011 11:07:41 AM
Pro-Pharmaceuticals, Inc. (PRW) to Hold Conference Call to Provide Update Following Company’s Annual Meeting of Stockholders 5/20/2011 8:30:17 AM
Pro-Pharmaceuticals, Inc. (PRW) Reports First Quarter 2011 Financial Results 5/13/2011 10:38:40 AM
Pro-Pharmaceuticals, Inc. (PRW)' Presentation at Noble Financial Capital Markets' Seventh Annual Equity Conference to Be Webcast Live 5/10/2011 10:28:27 AM
Pro-Pharmaceuticals, Inc. (PRW) Selects SAFC to Ramp-up the Manufacture of DAVANAT(R) for Anticipated Use in Clinical Trials & Sales in Colombia 5/3/2011 11:24:57 AM
Pro-Pharmaceuticals, Inc. (PRW) Expands Patent Coverage to Japan 4/25/2011 8:33:12 AM
Ludwig Institute For Cancer Research (LICR) and Pro-Pharmaceuticals, Inc. (PRW) Discover That DAVANAT(R) Enhances the Ability of Anti-Tumor T Lymphocytes to Kill Tumor Cells 4/20/2011 8:45:23 AM
Pro-Pharmaceuticals, Inc. (PRW) Expands Patent Portfolio with New Patents in the U.S. and Australia 3/22/2011 9:09:50 AM
Pro-Pharmaceuticals, Inc. (PRW) Reports Full Year and Fourth Quarter 2010 Financial Results 3/15/2011 9:52:48 AM
12345678910...